Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Contract Research & Services
Return to: PBR Home | Contract Research & Services
Today in Contract Research & Services

Contract Research & Services

Roche’s phase III study of Gazyva meets primary endpoint early Roche's Gazyva drug demonstrated superior progression-free survival compared to Mabthera/Rituxan in people with previously untreated follicular lymphoma in the phase III Gallium study that met its primary endpoint early. Contract Research & Services > Clinical Trials > News

Latest Contract Research & Services News by Sector

Select a sector from the list or browse by sector below:

Clinical Trials

Symbiomix reports positive results for SYM-1219 in bacterial vaginosis
By PBR Staff Writer
Symbiomix Therapeutics' SYM-1219 (secnidazole) has achieved statistically and clinically significant results across all primary and secondary endpoints in phase 3 trial for bacterial vaginosis (BV).
Contract Research & Services > Clinical Trials > News
Roche’s phase III study of Gazyva meets primary endpoint early
By PBR Staff Writer
Roche's Gazyva drug demonstrated superior progression-free survival compared to Mabthera/Rituxan in people with previously untreated follicular lymphoma in the phase III Gallium study that met its primary endpoint early.
Contract Research & Services > Clinical Trials > News

Contract Research

Sanofi Genzyme forms multiple sclerosis research collaboration with Johns Hopkins School of Medicine
Sanofi Genzyme, the specialty care global business unit of Sanofi, announced a research collaboration with the Johns Hopkins School of Medicine that will focus on novel strategies aimed at advancing the understanding of underlying causes of disease progression in multiple sclerosis (MS).
Contract Research & Services > Contract Research > News
HTG Molecular Diagnostics signs immuno-oncology research collaboration deal with Bristol-Myers Squibb
HTG Molecular Diagnostics has formed a research collaboration agreement with Bristol-Myers Squibb to evaluate the potential for immuno-oncology molecular profiling in multiple tumor types.
Contract Research & Services > Contract Research > News

Contract Services

PDL BioPharma commits to equity investment in Noden Pharma
PDL BioPharma has committed to an equity investment in Noden Pharma DAC, a new privately held company that has executed a purchase agreement with Novartis to acquire exclusive worldwide rights to manufacture, market, and sell the branded prescription medicine product sold under the name Tekturna and Tekturna HCT in the US and Rasilez and Rasilez HCT in the rest of the world.
Contract Research & Services > Contract Services > News
BioPharma Services wins $20m contract from FDA's Center for Drug Evaluation and Research
BioPharma Services USA, Inc. (BioPharma) has been awarded a 5-year, $20m contract with the Center for Drug Evaluation and Research (CDER), a division of the US Food and Drug Administration (FDA).
Contract Research & Services > Contract Services > News